Klotho
Klotho (α-Klotho) — Anti-Aging Protein/Peptide
Klotho is a protein encoded by the KL gene, named after the Greek Fate who spins the thread of life. Circulating α-Klotho levels decline with age by approximately 40% between ages 40 and 80, and low Klotho strongly predicts accelerated cognitive decline, cardiovascular disease, bone loss, and mortality. Animal models demonstrate that Klotho overexpression extends lifespan 20–30%, while Klotho deficiency accelerates ageing across multiple organ systems. Research into exogenous Klotho peptide fragments is advancing rapidly.
Mechanism of Action
Klotho acts as a co-receptor for fibroblast growth factor 23 (FGF23) in the kidney, regulating phosphate and vitamin D metabolism. However, its systemic anti-aging effects extend far beyond this co-receptor role through its shed circulating form (sKlotho — the KL1 domain fragment released into blood).
Circulating sKlotho has diverse protective effects: it activates FOXO transcription factors (longevity pathway), inhibits IGF-1/insulin signalling (extending lifespan in multiple model organisms), suppresses Wnt signalling in cancer contexts, reduces oxidative stress via upregulation of antioxidant enzymes, and protects endothelial cells from premature senescence.
In the brain, Klotho enhances synaptic plasticity and cognitive function via NMDA receptor modulation and BDNF pathway interaction. A naturally occurring human variant (KL-VS) that increases Klotho levels by ~10% is associated with a 30% reduced risk of Alzheimer's disease in heterozygous carriers — directly linking circulating Klotho to human cognitive longevity.
Research Evidence
Klotho research has expanded dramatically since 2000. The most compelling recent finding was a 2023 Nature paper showing a single injection of Klotho fragment in aged mice produced sustained cognitive improvements — one of the most dramatic single-dose anti-aging results in recent neuroscience.
Klotho Deficiency Accelerates Ageing; Overexpression Extends Lifespan 20–30%
Discovery paper: Mice with disrupted Klotho gene developed premature ageing syndrome. Klotho-overexpressing mice lived 20–30% longer than controls with reduced age-related pathology across multiple organ systems.
Single Klotho Injection Restores Cognitive Function in Aged Primates
A single systemic injection of Klotho KL1 fragment restored working memory, attention, and executive function in aged rhesus macaques to levels comparable to young adults — with effects persisting for at least 2 weeks.
Typical Research Protocol
Human Klotho protocols are not yet established. Research is at the translational stage with active clinical trials. Commercially available "Klotho" peptide products vary widely in characterisation and purity. This is a frontier research area — most researchers are monitoring clinical trial progress rather than pursuing experimental self-administration.
Safety Profile
Reported Side Effects
- Unknown (insufficient human data)
Contraindications
- Active malignancy (Klotho suppresses tumour-suppressive Wnt in some cancers — complex dual role)
- Pregnancy (no data)
- Severe hypophosphataemia (Klotho-FGF23 pathway regulation)
Common Research Stacks
Frequently Asked Questions
Is Klotho available as a supplement?
No pharmaceutical-grade Klotho preparation is approved or commercially available for human use. Some supplement companies market products as "Klotho support" (typically containing compounds like quercetin or vitamin D that modestly upregulate endogenous Klotho), but actual Klotho protein is not available as a consumer supplement. Exogenous Klotho peptide fragment research is in early clinical trials.
How can I increase my Klotho levels naturally?
Several lifestyle and dietary factors modestly increase circulating Klotho: aerobic exercise (particularly resistance training) is the strongest natural Klotho upregulator. Vitamin D optimisation (Klotho and vitamin D are closely linked hormonally), magnesium sufficiency, omega-3 fatty acids, and caloric restriction all support Klotho expression. The KL-VS variant carriers have genetically elevated Klotho regardless of lifestyle.
What is the relationship between Klotho and Alzheimer's disease?
The link is compelling at multiple levels: Klotho levels are 30–40% lower in AD patients than age-matched controls; the KL-VS variant that raises Klotho by 10% reduces AD risk by 30% in heterozygous carriers; and Klotho protects against amyloid-beta toxicity in cell models. The 2023 primate data showing cognitive restoration from a single Klotho injection has intensified clinical trial interest in AD.
Are there clinical trials for Klotho in humans?
Several Phase 1/2 trials for Klotho fragment administration are underway as of 2026 — particularly focused on cognitive decline, chronic kidney disease (where Klotho decline is most severe), and cardiovascular disease. These trials are characterising safety, pharmacokinetics, and early efficacy signals. Clinical trial results over the next 2–3 years will determine whether Klotho therapy becomes a realistic longevity intervention.
What does Klotho do in the kidneys?
The kidneys are the primary site of Klotho expression and release. Renal Klotho acts as the co-receptor for FGF23, the phosphate-regulating hormone. This kidney-Klotho-FGF23 axis controls blood phosphate and active vitamin D levels. Chronic kidney disease dramatically depletes Klotho, which explains why CKD is a state of accelerated cardiovascular and systemic ageing — the Klotho depletion drives vascular calcification, bone loss, and cardiac damage.
Key Research References
- Kuro-o M et al. (1997). Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature.
- Leon J et al. (2023). Peripheral administration of the human Klotho protein promotes resilience and rescues the cognitive decline. Nature Aging.
Explore more Longevity research compounds
Browse Longevity →